Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Ayurvedic treatment and Yoga Basti therapy improved a woman's PCOS symptoms.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

The document explains various skin conditions and their treatments.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.